» Articles » PMID: 33788840

SARS-CoV-2 Serological Testing in Frontline Health Workers in Zimbabwe

Abstract

Background: In order to protect health workers from SARS-CoV-2, there is need to characterise the different types of patient facing health workers. Our first aim was to determine both the infection status and seroprevalence of SARS-CoV-2 in health workers. Our second aim was to evaluate the occupational and demographic predictors of seropositivity to inform the country's infection prevention and control (IPC) strategy.

Methods And Principal Findings: We invited 713 staff members at 24 out of 35 health facilities in the City of Bulawayo in Zimbabwe. Compliance to testing was defined as the willingness to uptake COVID-19 testing by answering a questionnaire and providing samples for both antibody testing and PCR testing. SARS-COV-2 antibodies were detected using a rapid diagnostic test kit and SAR-COV-2 infection was determined by real-time (RT)-PCR. Of the 713 participants, 635(89%) consented to answering the questionnaire and providing blood sample for antibody testing while 560 (78.5%) agreed to provide nasopharyngeal swabs for the PCR SARS-CoV-2 testing. Of the 635 people (aged 18-73) providing a blood sample 39.1% reported a history of past COVID-19 symptoms while 14.2% reported having current symptoms of COVID-19. The most-prevalent co-morbidity among this group was hypertension (22.0%) followed by asthma (7.0%) and diabetes (6.0%). The SARS-CoV-2 sero-prevalence was 8.9%. Of the 560 participants tested for SARS-CoV-2 infection, 2 participants (0.36%) were positive for SAR-CoV-2 infection by PCR testing. None of the SARS-CoV-2 antibody positive people were positive for SAR-CoV-2 infection by PCR testing.

Conclusion And Interpretation: In addition to clinical staff, several patient-facing health workers were characterised within Zimbabwe's health system and the seroprevalence data indicated that previous exposure to SAR-CoV-2 had occurred across the full spectrum of patient-facing staff with nurses and nurse aides having the highest seroprevalence. Our results highlight the need for including the various health workers in IPC strategies in health centres to ensure effective biosecurity and biosafety.

Citing Articles

Prevalence of COVID-19 and associated factors among healthcare workers in the war-torn Tigray, Ethiopia.

Abera B, Gebrecherkos T, Weledegebriel M, Abreha G PLoS One. 2024; 19(11):e0310128.

PMID: 39576201 PMC: 11581278. DOI: 10.1371/journal.pone.0310128.


Understanding the impact of the COVID-19 pandemic and its control measures on women and children: A Zimbabwe case study.

Taruvinga T, Chingono R, Olaru I, Masiye K, Madanhire C, Munhenzva S medRxiv. 2024; .

PMID: 38883725 PMC: 11177921. DOI: 10.1101/2024.06.03.24308400.


What does equitable global health research and delivery look like? Tackling Infections to Benefit Africa (TIBA) partnership as a case study.

Mutapi F, Banda G, Woolhouse M BMJ Glob Health. 2023; 8(3).

PMID: 36963785 PMC: 10040064. DOI: 10.1136/bmjgh-2022-011028.


Peptide microarray analysis of in-silico predicted B-cell epitopes in SARS-CoV-2 sero-positive healthcare workers in Bulawayo, Zimbabwe.

Vengesai A, Naicker T, Midzi H, Kasambala M, Muleya V, Chipako I Acta Trop. 2022; 238:106781.

PMID: 36460093 PMC: 9705268. DOI: 10.1016/j.actatropica.2022.106781.


Frontline healthcare workers' experiences of providing care during the COVID-19 pandemic at a COVID-19 centre in Bulawayo, Zimbabwe: A phenomenological study.

Moyo I, Mavhandu-Mudzusi A, Haruzivishe C Curationis. 2022; 45(1):e1-e11.

PMID: 35792610 PMC: 9257684. DOI: 10.4102/curationis.v45i1.2292.


References
1.
Chersich M, Gray G, Fairlie L, Eichbaum Q, Mayhew S, Allwood B . COVID-19 in Africa: care and protection for frontline healthcare workers. Global Health. 2020; 16(1):46. PMC: 7227172. DOI: 10.1186/s12992-020-00574-3. View

2.
Shields A, Faustini S, Perez-Toledo M, Jossi S, Aldera E, Allen J . SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study. Thorax. 2020; 75(12):1089-1094. PMC: 7462045. DOI: 10.1136/thoraxjnl-2020-215414. View

3.
Lohse S, Pfuhl T, Berko-Gottel B, Rissland J, Geissler T, Gartner B . Pooling of samples for testing for SARS-CoV-2 in asymptomatic people. Lancet Infect Dis. 2020; 20(11):1231-1232. PMC: 7194818. DOI: 10.1016/S1473-3099(20)30362-5. View

4.
Schwartz J, King C, Yen M . Protecting Healthcare Workers During the Coronavirus Disease 2019 (COVID-19) Outbreak: Lessons From Taiwan's Severe Acute Respiratory Syndrome Response. Clin Infect Dis. 2020; 71(15):858-860. PMC: 7108122. DOI: 10.1093/cid/ciaa255. View

5.
Karamouzian M, Johnson C, Kerr T . Public health messaging and harm reduction in the time of COVID-19. Lancet Psychiatry. 2020; 7(5):390-391. PMC: 7185931. DOI: 10.1016/S2215-0366(20)30144-9. View